Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Minor ailments rated most viable service in PSNC strategy

Just over a third of respondents to a C+D poll said a combined minor ailments and emergency supply service is the most realistic of the negotiator's clinical suggestions


Readers have backed PSNC’s plans for a combined minor ailments and emergency supply service.

More than a third of respondents to a C+D poll said the combined service is the "most viable" of the options the negotiator suggested in its clinical plan for the sector earlier this month.

The same proportion said more repeat electronic dispensing was the most likely to work.

Sixteen percent of 270 respondents to the poll, which ran February 12-23, backed more pharmacists attaining independent prescriber status. 

Which of the services set out in PSNC’s clinical vision is the most viable for pharmacists to deliver if the 6% funding cut goes ahead?


PSNC was forced to defend its strategy earlier in the month after readers questioned where the money to fund the additional services would come from. 


More funding cut news... 

PSNC defends clinical vision in face of reader criticism

PSNC responds to funding cuts with 'clinical' vision

PSNC vows to fight ‘profoundly stupid’ 6% funding cut



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts